A mong the first million patients who received metformin in the U.S., 47 patients developed metforminassociated lactic acidosis (MALA), with 43 having predisposing factors for lactic acidosis (including moderate to severe renal failure and congestive heart failure) (1) . Although there was initial concern, studies have suggested that MALA is secondary to underlying conditions and represents a coincidental finding (2, 3) . While the current consensus is that the risk of lactic acidosis is negligible when metformin is used as labeled (4), we present a patient who developed MALA in the absence of currently recognized contraindications to metformin.
A 55-year-old man with hypertension, type 2 diabetes, and mild renal insufficiency (measured creatinine clearance 91 ml/min) presented with sudden onset of fatigue, vomiting, and altered mental status after performing strenuous yard work without sufficient hydration. His medications included nifedipine, captopril, hydrochlorothiazide, glyburide, and metformin.
The patient rapidly developed respiratory distress and hypotension necessitating intubation and vasoactive agents. Laboratory studies revealed a serum creatinine level of 9.4 mg/dl, pH 6.98, CO 2 Ͻ6 mmol/l, and lactic acid 27 mmol/l. Evaluation using a computed tomography scan and magnetic resonance angiography of the abdomen/pelvis, various cultures and cardiac echocardiogram could not reveal an etiology for lactic acidosis. Serum metformin level (ARUP Laboratories, Salt Lake City, UT) was 8 mg/l (therapeutic range 1-2). Continuous venovenous hemofiltration was initiated immediately. Conservative management was followed by rapid amelioration of his general status. He was extubated within 24 h, continuous venovenous hemofiltration was stopped after 36 h, and he was discharged 6 days after presentation without deficits.
This case is unique in that MALA developed in the absence of currently recognized risk factors or predisposing conditions. Although this patient had mild impairment of kidney function, contraindication criteria for the use of metformin were not met (5). The patient was taking 2 g metformin per day, which is within the recommended therapeutic range.
In our opinion, a threshold serum creatinine level above normal range should not be considered safe for metformin use because renal function can rapidly deteriorate in patients with even mild underlying kidney disease, resulting in accumulation of metformin and development of MALA. We suggest that consideration be given to avoiding metformin in patients with any degree of renal dysfunction. (Fig. 1) . The patient also complained of a "knot" in his right inguinal area. An incisional biopsy was taken from the foot lesion, which revealed a poorly differentiated melanoma covered by an intact epidermis and granulation tissue. The incisional biopsy was 0.8-cm thick, and melanoma extended to the deep margin. At presentation, the size and poor differentiation of the tumor made it impossible to assess the subtype of the original melanoma. The S-100 and HMB-45 stains (positive in melanoma cases) were strongly positive. A computed tomography of the chest, abdomen, and inguinal areas revealed metastasis to the inguinal lymph nodes and liver. The patient died 6 months later.
AMIR KAZORY
Although rare, melanomas can present as neuropathic foot ulcers in individuals with diabetes (1,2). Melanomas are located on the plantar surface in ϳ7% of cases (3) with the exception of Japanese patients, in whom the plantar surface is the most common location (4). Acral lentiginous melanoma is the most common melanoma type that presents on the plantar aspect of the foot (3). This type of melanoma is commonly amelanotic, frequently ulcerates (5), and does not exhibit the classic signs of malignant melanoma associated with the mnemonic aid "ABCD" (asymmetry, border, color, diameter). In a review (6) of 53 lower extremity melanomas, 11 of 18 (61%) misdiagnosed cases were on the plantar foot. All misdiagnosed lesions were histopathologically acral lenginous melanomas. Initial misdiagnoses included nonhealing ulcer, wart, tinea pedis, and onychomycosis. Another retrospective review (7) of palmoplantar melanoma found that misdiagnosis led to a median delay of treatment for 12 months and was associated with increased tumor thickness (5.0 vs. 1.5 mm) and a lower 5-year survival rate (15.4 vs. 68.9%).
We are not supposing that plantar melanoma occurs more frequently in individuals with diabetes. However, we believe there is a greater chance of misdiagnosis given this population's predilection toward plantar ulceration. An individual with peripheral sensory neuropathy is more likely to unknowingly ambulate on a plantar foot lesion, and this increased pressure and trauma can cause a lesion to initially resemble a diabetic foot ulcer. This case and short review emphasizes the importance of performing biopsies on chronic and atypical wounds early in the treatment algorithm of diabetic foot ulcers. 
I
n response to the interesting article by Barnett et al.
(1), we would like to offer the following comments. Diabetes control has been shown to improve with diet and exercise regimens (2, 3) . The degree of study participants' compliance with diet and exercise regimens may have confounded the change in A1C reported in the study (1) . Also, the independent effect of BMI on both diabetes control and response to therapy has been studied extensively (4). The effect of modification of baseline BMI on diabetes control among various strata of BMI in both study groups needs clarification.
The open-blinded design of the study (1), especially since it involves diabetes education and self monitoring, can significantly impact internal validity due to both performance bias of the subject with respect to compliance with lifestyle modifications as well as detection bias of the health care providers in ascertaining adverse outcomes (5) . In addition, the noninferiority design offers no protection against a predetermined idea of equivalence by the investigator, who could allocate similar scores to responses and events of all study subjects (6) . 
